HEPS
D-Market Elektronik Hizmetler ve Ticaret A.S.
HEPS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over HEPS overall, supported by stronger valuation.
HEPS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
HEPS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
HEPS PE Valuation
HEPS has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
HEPS Forward outlook
There aren't enough analyst estimates for HEPS to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
HEPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.44 | -$0.31 |
| Q1 2026 | -$0.39 | -$0.28 |
| Q4 2025 | -$0.35 | -$0.26 |
| Q3 2025 | -$0.19 | -$0.10 |
| Q2 2025 | -$0.13 | -$0.05 |
| Q1 2025 | -$0.11 | -$0.10 |
| Q4 2024 | -$0.09 | -$0.06 |
| Q3 2024 | -$0.09 | -$0.08 |
HEPS lost $0.44 per share over the past year, and its loss has widened in each of the last six quarters.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over HEPS on earnings quality, reporting a profit while its opponent remains loss making.
HEPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $453.9M | +36% |
| Q1 2026 | $460.4M | +61% |
| Q4 2025 | $603.7M | +48% |
| Q3 2025 | $396.4M | +63% |
| Q2 2025 | $333.2M | +23% |
| Q1 2025 | $286.3M | -7.9% |
| Q4 2024 | $406.7M | +46% |
| Q3 2024 | $243.6M | +1.7% |
HEPS has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.9% | -3.1 points |
| Q1 2026 | -1.9% | +1.9 points |
| Q4 2025 | 0.9% | +0.3 points |
| Q3 2025 | -3% | -3.2 points |
| Q2 2025 | 0.2% | +0.5 points |
| Q1 2025 | -3.8% | -2.9 points |
| Q4 2024 | 0.7% | +2.6 points |
| Q3 2024 | 0.3% | +2.3 points |
HEPS's operating margin was −2.9% last quarter, down 3.1 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over HEPS on profitability, with a higher operating margin.
HEPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $29.3M | -56% |
| Q1 2026 | -$61.5M | -$60.6M |
| Q4 2025 | $14.9M | +$15.4M |
| Q3 2025 | $438.9K | +30% |
| Q2 2025 | $66.5M | +$67.4M |
| Q1 2025 | -$928.4K | -510% |
| Q4 2024 | -$582.5K | -133% |
| Q3 2024 | $337.1K | -66% |
HEPS's free cash flow was −$17M over the past year, against $65M the year before.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over HEPS on cash generation, producing positive trailing cash flow while its opponent burns cash.
HEPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +3.1M shares |
| 1 year | +15% | +47.7M shares |
| 3 years | +14% | +44.2M shares |
| 5 years | +14% | +44.5M shares |
| Available history | +14% | +44.5M shares |
HEPS has 371M diluted shares, up 15% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HEPS hasn't bought back shares in the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over HEPS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
HEPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -6.3x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
HEPS has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
HEPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 60.1 | Neutral |
HEPS's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
HEPS PE vs Consumer Cyclical Sector
| Metric | HEPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HEPS has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
HEPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 1.1% above |
| 20 week MA | $2.73 | 0.7% below |
| 50 week MA | $2.73 | 0.7% below |
| 100 week MA | $2.79 | 2.9% below |
| 200 week MA | $2.28 | 19% above |
HEPS has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
HEPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $14.1 | $2.05 | -85% |
| 2022 | $2.05 | $0.69 | -66% |
| 2023 | $0.69 | $1.80 | +161% |
| 2024 | $1.80 | $3.26 | +81% |
| 2025 | $3.26 | $2.52 | -23% |
| 2026 YTD | $2.52 | $2.71 | +7.5% |
HEPS has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.